載入...
δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8(+) T cell activation
As classical therapy method of advanced hepatocellular carcinoma (HCC) is not effective enough, HCC immunotherapy is a hot spot for research in recent years. Although in recent years, immune checkpoint inhibitors are focused in cancer therapy, vaccines and adoptive cell therapy (ACT), as traditional...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136873/ https://ncbi.nlm.nih.gov/pubmed/30221043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1450713 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|